Biosonix gets CE mark for FlowGuard

Israel-based blood-flow technology developer Biosonix has received the European CE mark for its FlowGuard technology. Designed for use in neurosurgical and vascular surgery settings, FlowGuard employs digital ultrasound technology to provide noninvasive measurements of blood flow in real-time. It also provides a spectrum of additional hemodynamic parameters, according to radiopharmaceutical developer Neoprobe, which is bidding to buy Biosonix.

By AuntMinnie.com staff writers
October 4, 2001

Related Reading

Neoprobe to buy Biosonix, September 7, 2001

Copyright © 2001 AuntMinnie.com

Page 1 of 512
Next Page